7Baggers
 Mineralys Therapeutics Shares Fall Following Executives' Stock Sale  MarketScreener Fri, 14 Nov 2025 17:13:36 GMT
 mineralys therapeutic stock falls after insider sales  Investing.com Fri, 14 Nov 2025 17:00:50 GMT
 Mineralys Therapeutics’ Stock Dips Amid Earnings Miss  TipRanks Fri, 14 Nov 2025 15:25:42 GMT
 Mineralys therapeutics (MLYS) CFO Adam Levy sells $5.36m in stock  Investing.com Nigeria Fri, 14 Nov 2025 09:39:08 GMT
 Mineralys Therapeutics CEO Congleton sells $9 million in stock By Investing.com  Investing.com Nigeria Fri, 14 Nov 2025 09:34:47 GMT
 Mineralys Therapeutics director Karydas sells $689k in shares  Investing.com India Fri, 14 Nov 2025 01:02:12 GMT
 Mineralys Therapeutics director Gold sells $1.57m in MLYS stock By Investing.com  Investing.com South Africa Fri, 14 Nov 2025 00:11:15 GMT
 mineralys therapeutics director karydas sells $689k in shares by investing.com  Investing.com Canada Thu, 13 Nov 2025 08:00:00 GMT
 Wells Fargo Reaffirms Their Buy Rating on Mineralys Therapeutics, Inc. (MLYS)  The Globe and Mail Wed, 12 Nov 2025 15:56:38 GMT
 mineralys at guggenheim conference: promising hypertension treatment  Investing.com Tue, 11 Nov 2025 17:22:50 GMT
 mineralys therapeutics reports q3 eps (52c), consensus (61c)  TipRanks Tue, 11 Nov 2025 15:45:39 GMT
 Why Mineralys Therapeutics Stock is Gaining Momentum  TipRanks Tue, 11 Nov 2025 15:15:58 GMT
 mineralys therapeutics stock hits all-time high at 44.8 usd by investing.com  Investing.com Australia Tue, 11 Nov 2025 06:53:36 GMT
 Decoding Mineralys Therapeutics Inc (MLYS): A Strategic SWOT Ins  GuruFocus Tue, 11 Nov 2025 05:22:13 GMT
 Mineralys Therapeutics Reports Q3 2025 Financial Results  TipRanks Tue, 11 Nov 2025 04:14:58 GMT
 mineralys therapeutics q3 2025 earnings call transcript  MarketBeat Mon, 10 Nov 2025 22:30:00 GMT
 mineralys therapeutics falls despite better-than-expected q3 loss by investing.com  Investing.com Nigeria Mon, 10 Nov 2025 22:19:00 GMT
 mineralys therapeutics, inc. sec 10-q report  TradingView Mon, 10 Nov 2025 22:13:01 GMT
 Mineralys Therapeutics Cuts Losses And Builds Up Cash Pile  Finimize Mon, 10 Nov 2025 22:09:53 GMT
 mineralys therapeutics q3 loss narrows  MarketScreener Mon, 10 Nov 2025 21:40:39 GMT
 Mineralys Therapeutics Q3 net loss narrows  TradingView Mon, 10 Nov 2025 21:15:33 GMT
 Mineralys Therapeutics stock hits all-time high at 44.8 USD  Investing.com Mon, 10 Nov 2025 21:07:20 GMT
 Mineralys Therapeutics reports Q3 EPS (52c), consensus (61c)  TipRanks Mon, 10 Nov 2025 21:00:00 GMT
 Mineralys Stocks Fly on Positive News  StocksToTrade Mon, 10 Nov 2025 19:05:00 GMT
 data for lorundrostat in chronic kidney disease and  GlobeNewswire Fri, 07 Nov 2025 23:10:00 GMT
 (mlys) risk channels and responsive allocation  news.stocktradersdaily.com Fri, 07 Nov 2025 16:14:02 GMT
 Mineralys Therapeutics to Participate in Upcoming Investor Conferences  Yahoo Finance Wed, 05 Nov 2025 08:00:00 GMT
 mineralys therapeutics to release q3 financial results on november 10  Traders Union Mon, 03 Nov 2025 21:15:28 GMT
 apogee therapeutics to participate in upcoming conferences  The Manila Times Mon, 03 Nov 2025 12:36:59 GMT

Mineralys Therapeutics, Inc.
(NASDAQ:MLYS) 

MLYS stock logo

Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase in...

Founded: 2019
IPO Price: $16 (Feb 10, 2023)
CEO: Jon Congleton  
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends